Apogee Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VR ADVISER, LLC | 02/17/2026 | 8.49 M | $641.08 M | 0.00% | 14.45% |
| FMR LLC | 02/17/2026 | 8.23 M | $620.83 M | 18.92% | 13.99% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 4.75 M | $358.27 M | 0.48% | 8.08% |
| BLACKROCK, INC. | 02/12/2026 | 3.78 M | $285.62 M | 40.88% | 6.44% |
| VANGUARD GROUP INC | 01/29/2026 | 2.86 M | $215.71 M | 27.26% | 4.86% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 2.73 M | $206.25 M | 189,522.21% | 4.65% |
| RTW INVESTMENTS, LP | 02/17/2026 | 2.71 M | $204.71 M | 0.00% | 4.61% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 2.33 M | $175.92 M | 72.39% | 3.97% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 2.18 M | $164.83 M | 1.17% | 3.72% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 2.06 M | $155.70 M | 324.42% | 3.51% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 02/17/2026 | 2.05 M | $154.63 M | 0.00% | 3.49% |
| STATE STREET CORP | 02/13/2026 | 1.69 M | $127.58 M | 2.09% | 2.88% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.37 M | $103.64 M | 20.68% | 2.34% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.24 M | $93.38 M | 64.84% | 2.10% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 1.23 M | $93.21 M | 5.24% | 2.10% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 1.12 M | $84.78 M | -26.19% | 1.91% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 1.09 M | $82.55 M | -22.93% | 1.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.06 M | $79.96 M | 18.70% | 1.80% |
| UBS GROUP AG | 01/29/2026 | 974.83 K | $73.58 M | 21.93% | 1.66% |
| MERCER GLOBAL ADVISORS INC /ADV | 02/18/2026 | 890.67 K | $67.23 M | -8.23% | 1.52% |
| MORGAN STANLEY | 02/13/2026 | 890.26 K | $67.20 M | 91.47% | 1.51% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 793.70 K | $59.91 M | 101.49% | 1.35% |
| CITADEL ADVISORS LLC | 02/17/2026 | 766.98 K | $57.89 M | -34.40% | 1.31% |
| 02/12/2026 | 583.59 K | $44.05 M | 100.00% | 0.99% | |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 578.63 K | $43.67 M | 100.00% | 0.98% |
| BRAIDWELL LP | 02/17/2026 | 575.07 K | $43.41 M | -60.03% | 0.98% |
| NOVO HOLDINGS A/S | 02/17/2026 | 570.00 K | $43.02 M | 14.00% | 0.97% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 565.41 K | $42.68 M | -5.70% | 0.96% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 550.00 K | $41.51 M | 29.41% | 0.94% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 534.85 K | $40.37 M | -5.41% | 0.91% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 503.54 K | $38.01 M | -3.92% | 0.86% |
| AVORO CAPITAL ADVISORS LLC | 03/16/2026 | 500.00 K | $37.74 M | 100.00% | 0.85% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 02/17/2026 | 480.45 K | $36.26 M | 28.32% | 0.82% |
| FIRST TURN MANAGEMENT, LLC | 02/13/2026 | 474.84 K | $35.84 M | 17.88% | 0.81% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 451.00 K | $34.04 M | -38.28% | 0.77% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 436.02 K | $32.91 M | 100.00% | 0.74% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 388.26 K | $29.31 M | 6.88% | 0.66% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 381.36 K | $28.79 M | 19.21% | 0.65% |
| GREAT POINT PARTNERS LLC | 02/17/2026 | 374.00 K | $28.23 M | 23.03% | 0.64% |
| NORTHERN TRUST CORP | 02/17/2026 | 327.38 K | $24.71 M | 15.08% | 0.56% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 312.88 K | $23.62 M | 100.00% | 0.53% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/17/2026 | 284.99 K | $21.51 M | 100.00% | 0.48% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 255.44 K | $19.28 M | 100.00% | 0.43% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 240.00 K | $18.12 M | 2.13% | 0.41% |
| DIADEMA PARTNERS LP | 02/17/2026 | 211.10 K | $15.93 M | 65.70% | 0.36% |
| WOODLINE PARTNERS LP | 02/17/2026 | 210.47 K | $15.89 M | 267.17% | 0.36% |
| 02/17/2026 | 192.00 K | $14.49 M | 100.00% | 0.33% | |
| CANDRIAM S.C.A. | 04/30/2026 | 191.32 K | $14.44 M | 51.74% | 0.33% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 140.73 K | $10.62 M | -67.31% | 0.24% |
| BARCLAYS PLC | 02/13/2026 | 133.19 K | $10.05 M | -79.26% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apogee Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 249 institutional investors and hedge funds held shares of Apogee Therapeutics Inc.. The most heavily invested institutionals were:
UBS Group AG: 1.14 M
JENNISON ASSOCIATES LLC: 585,016
FEDERATED HERMES, INC.: 442,738
VANGUARD FIDUCIARY TRUST CO: 368,961
Pictet Asset Management Holding SA: 261,050
Candriam S.C.A.: 223,541
118.71% of Apogee Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 74.46 M shares in the last 24 months. This purchase volume represents approximately $5.58 B in transactions.